je.st
news
AstraZeneca reverses $285m charge
2013-09-04 13:06:45| Biotech - Topix.net
AstraZeneca has reversed a previous pre-tax impairment charge of $285 million after launching a final-stage Phase III clinical trial for the experimental drug olaparib in ovarian cancer.
Tags: charge
reverses
astrazeneca
285m
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||